| |
| |
|
| Insider
Information: |
Shannon Timothy M |
| Relationship: |
Director |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
164,303 |
|
|
Indirect Shares
|
12,222,376 |
|
|
| Direct
Value |
$5,631,010 |
|
|
|
Indirect Value
|
$53,511,753 |
|
|
| Total
Shares |
12,386,679 |
|
|
| Total
Value |
$59,142,763 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
11
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-11.0
|
| Percentage
Gain/Loss : |
 80.9%
|
 -553.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celldex Therapeutics Inc |
CLDX |
Director |
2014-06-04 |
83,212 |
|
0 |
Premium* |
|
|
Cytomx Therapeutics, Inc. |
CTMX |
Director |
2016-11-29 |
448 |
2016-11-29 |
3,244,381 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Director |
2021-09-07 |
80,643 |
2021-09-07 |
1,653,128 |
Premium* |
|
|
Nextcure, Inc. |
NXTC |
Director |
2019-05-13 |
0 |
2019-05-13 |
2,254,442 |
Premium* |
|
|
Ideaya Biosciences, Inc. |
IDYA |
Director |
2019-05-28 |
0 |
2019-05-28 |
2,660,713 |
Premium* |
|
|
Rallybio Corp |
RLYB |
Director |
2021-07-28 |
0 |
2021-08-02 |
2,409,712 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-09-07 |
4 |
S |
$87.98 |
$3,243,796 |
I/I |
(36,411) |
1,653,128 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-09-03 |
4 |
S |
$85.47 |
$2,770,146 |
I/I |
(32,387) |
1,689,539 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-09-02 |
4 |
S |
$85.42 |
$4,443,116 |
I/I |
(51,765) |
1,721,926 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-09-01 |
4 |
S |
$85.67 |
$6,915,221 |
I/I |
(79,437) |
1,773,691 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-08-31 |
4 |
S |
$85.39 |
$5,078,151 |
I/I |
(59,355) |
1,853,128 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-08-30 |
4 |
S |
$85.19 |
$5,064,458 |
I/I |
(58,838) |
1,912,483 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-08-27 |
4 |
S |
$85.38 |
$3,845,951 |
I/I |
(45,026) |
1,971,321 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-08-26 |
4 |
S |
$85.12 |
$996,970 |
I/I |
(11,712) |
2,016,347 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-08-25 |
4 |
S |
$85.03 |
$1,213,144 |
I/I |
(14,267) |
2,028,059 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-08-24 |
4 |
S |
$86.95 |
$800,818 |
I/I |
(9,203) |
2,042,326 |
0 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2021-08-23 |
4 |
S |
$88.01 |
$140,728 |
I/I |
(1,599) |
2,051,529 |
0 |
% |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2021-08-02 |
4 |
B |
$13.00 |
$999,999 |
I/I |
76,923 |
2,409,712 |
2.1 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,332,789 |
2,332,789 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2020-06-17 |
4 |
B |
$30.26 |
$60,520 |
D/D |
2,000 |
79,546 |
2.39 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2020-06-02 |
4 |
B |
$32.30 |
$96,900 |
D/D |
3,000 |
77,546 |
2.39 |
% |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2020-05-26 |
4 |
OE |
$22.06 |
$285,081 |
D/D |
12,923 |
74,546 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2020-03-20 |
4 |
B |
$40.00 |
$100,000 |
D/D |
2,500 |
61,623 |
2.39 |
% |
|
| IDYA |
Ideaya Biosciences, Inc. |
Director |
– • – |
2019-05-28 |
4 |
B |
$10.00 |
$4,000,000 |
I/I |
400,000 |
2,660,713 |
2.1 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
Director |
– • – |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,260,713 |
2,260,713 |
0 |
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • – |
2019-05-13 |
4 |
B |
$15.00 |
$750,000 |
I/I |
50,000 |
2,254,442 |
2.1 |
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • – |
2019-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,204,442 |
2,204,442 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2019-03-28 |
4 |
B |
$14.69 |
$51,410 |
D/D |
3,500 |
58,898 |
2.39 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
4,989,554 |
4,989,554 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2018-10-01 |
4 |
B |
$16.00 |
$64,000 |
D/D |
4,000 |
55,398 |
2.39 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-11-29 |
4 |
S |
$11.18 |
$247,008 |
I/I |
(22,086) |
3,244,381 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
